Ranjan Kc
About Ranjan Kc
Ranjan Kc is a scientist specializing in analytical development, currently working at Ocugen since 2022. He has extensive experience in cell and gene therapy, having previously held positions at Eurofins PSS Insourcing Solutions, Cleveland Clinic, and Children's Hospital of Philadelphia.
Current Role at Ocugen
Ranjan Kc currently serves as a Scientist in Analytical Development at Ocugen, a position he has held since 2022. He is based in Malvern, Pennsylvania, United States. In this role, he focuses on analytical method development, qualification, and validation, particularly in the field of cell and gene therapy. His responsibilities include collaborating with external contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) to improve method development and lot-release testing processes.
Previous Experience at Eurofins PSS Insourcing Solutions
Prior to his current position, Ranjan Kc worked as a Scientist in Cell & Gene Therapy at Eurofins PSS Insourcing Solutions from 2020 to 2022. During his two-year tenure, he contributed to various projects related to cell and gene therapy, enhancing his expertise in analytical development and regulatory compliance.
Research Background at Cleveland Clinic and Children's Hospital of Philadelphia
Ranjan Kc has significant research experience, having worked as a Research Associate at Cleveland Clinic from 2017 to 2018. He spent nine months in the Cleveland/Akron, Ohio area before moving to the Children's Hospital of Philadelphia, where he served as a Research Associate from 2018 to 2020 for two years. His roles in these institutions involved conducting research that contributed to advancements in medical science.
Educational Qualifications
Ranjan Kc holds a Doctor of Philosophy (PhD) in Medicine from Inha University, where he studied from 2006 to 2010. He also earned a Master's degree in Public Health and Environmental Microbiology from Nepal Jobs, completing his studies from 2001 to 2003. His educational background provides a strong foundation for his work in analytical development and research.
Authorship and Regulatory Compliance
In his professional career, Ranjan Kc has authored the Analytical Development section for Investigational New Drug (IND) filings. His work ensures compliance with regulatory standards, highlighting his commitment to maintaining high-quality practices in pharmaceutical development.